Japanese gastric cancer treatment guidelines 2014 (ver. 4)

被引：2163
作者：
Japanese Gastric Cancer Association
机构：
[1] Japanese Gastr Canc Assoc, Kamigyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan
来源：
GASTRIC CANCER | 2017年 / 20卷 / 01期
关键词：
RANDOMIZED PHASE-III; S-1 PLUS CISPLATIN; LYMPH-NODE DISSECTION; ADJUVANT CHEMOTHERAPY; NEOADJUVANT CHEMOTHERAPY; COMBINATION CHEMOTHERAPY; PERITONEAL METASTASIS; 2ND-LINE CHEMOTHERAPY; DISTAL GASTRECTOMY; SURGICAL RESECTION;
D O I：
10.1007/s10120-016-0622-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：1 / 19
页数：19
相关论文
共 58 条
[1]   Intraoperative lavage for cytological examination in 1,297 patients with gastric carcinoma [J].
Bando, E ;
Yonemura, Y ;
Takeshita, Y ;
Taniguchi, K ;
Yasui, T ;
Yoshimitsu, Y ;
Fushida, S ;
Fujimura, T ;
Nishimuua, G ;
Miwa, K .
AMERICAN JOURNAL OF SURGERY, 1999, 178 (03) :256-262
[2]  
Bando E, 10 INT GASTR CANC C
[3]  
Bang YJ, 2010, LANCET, V376, P1302
[4]   Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study [J].
Boku, Narikazu ;
Yamamoto, Seiichiro ;
Fukuda, Haruhiko ;
Shirao, Kuniaki ;
Doi, Toshihiko ;
Sawaki, Akira ;
Koizumi, Wasaburo ;
Saito, Hiroshi ;
Yamaguchi, Kensei ;
Takiuchi, Hiroya ;
Nasu, Junichiro ;
Ohtsu, Atsushi .
LANCET ONCOLOGY, 2009, 10 (11) :1063-1069
[5]   Survival benefit of combined curative resection of the stomach (D2 resection) and liver in gastric cancer patients with liver metastases [J].
Cheon, S. H. ;
Rha, S. Y. ;
Jeung, H. -C. ;
Im, C. -K. ;
Kim, S. H. ;
Kim, H. R. ;
Ahn, J. B. ;
Roh, J. K. ;
Noh, S. H. ;
Chung, H. C. .
ANNALS OF ONCOLOGY, 2008, 19 (06) :1146-1153
[6]   Capecitabine and oxaliplatin for advanced esophagogastric cancer [J].
Cunningham, David ;
Starling, Naureen ;
Rao, Sheela ;
Iveson, Timothy ;
Nicolson, Marianne ;
Coxon, Fareeda ;
Middleton, Gary ;
Daniel, Francis ;
Oates, Jacqueline ;
Norman, Andrew Richard .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (01) :36-46
[7]   Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial [J].
Fuchs, Charles S. ;
Tomasek, Jiri ;
Yong, Cho Jae ;
Dumitru, Filip ;
Passalacqua, Rodolfo ;
Goswami, Chanchal ;
Safran, Howard ;
dos Santos, Lucas Vieira ;
Aprile, Giuseppe ;
Ferry, David R. ;
Melichar, Bohuslav ;
Tehfe, Mustapha ;
Topuzov, Eldar ;
Zalcberg, John Raymond ;
Chau, Ian ;
Campbell, William ;
Sivanandan, Choondal ;
Pikiel, Joanna ;
Koshiji, Minori ;
Hsu, Yanzhi ;
Liepa, Astra M. ;
Gao, Ling ;
Schwartz, Jonathan D. ;
Tabernero, Josep .
LANCET, 2014, 383 (9911) :31-39
[8]   Survival benefit of bursectomy in patients with resectable gastric cancer: interim analysis results of a randomized controlled trial [J].
Fujita, Junya ;
Kurokawa, Yukinori ;
Sugimoto, Tomoyuki ;
Miyashiro, Isao ;
Iijima, Shohei ;
Kimura, Yutaka ;
Takiguchi, Shuji ;
Fujiwara, Yoshiyuki ;
Mori, Masaki ;
Doki, Yuichiro .
GASTRIC CANCER, 2012, 15 (01) :42-48
[9]   Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial [J].
Fujitani, Kazumasa ;
Yang, Han-Kwang ;
Mizusawa, Junki ;
Kim, Young-Woo ;
Terashima, Masanori ;
Han, Sang-Uk ;
Iwasaki, Yoshiaki ;
Hyung, Woo Jin ;
Takagane, Akinori ;
Park, Do Joong ;
Yoshikawa, Takaki ;
Hahn, Seokyung ;
Nakamura, Kenichi ;
Park, Cho Hyun ;
Kurokawa, Yukinori ;
Bang, Yung-Jue ;
Park, Byung Joo ;
Sasako, Mitsuru ;
Tsujinaka, Toshimasa .
LANCET ONCOLOGY, 2016, 17 (03) :309-318
[10]   Adjuvant capecitabine plus oxaliplatin after D2 gastrectomy in Japanese patients with gastric cancer: a phase II study [J].
Fuse, Nozomu ;
Bando, Hideaki ;
Chin, Keisho ;
Ito, Seiji ;
Yoshikawa, Takaki ;
Tsuburaya, Akira ;
Terashima, Masanori ;
Kawashima, Yoshiyuki ;
Fukunaga, Tetsu ;
Gotoh, Masahiro ;
Emi, Yasunori ;
Yoshida, Kazuhiro ;
Oki, Eiji ;
Takahashi, Seiji ;
Kuriki, Hiroshi ;
Sato, Kumi ;
Sasako, Mitsuru .
GASTRIC CANCER, 2017, 20 (02) :332-340
123456